NASOPHARYNGEAL CARCINOMA
Clinical trials for NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study aims to zap cancer, spare healthy tissue
Disease control OngoingThis large trial is testing if doctors can safely shrink the area they target with radiation for patients with advanced nasopharyngeal cancer (a type of head and neck cancer). All patients get chemotherapy first, then are randomly assigned to have radiation aimed at either their …
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New cancer drug combo enters first human tests
Disease control OngoingThis is an early-stage study testing a new drug called DKY709, both alone and combined with another drug (PDR001), in adults with advanced solid tumors that have stopped responding to standard treatments. The main goal is to find safe doses and understand side effects. Researcher…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Frozen 'Super Cells' banked to fight Virus-Driven cancers
Disease control OngoingThis study tests a new treatment for cancers linked to the Epstein-Barr virus (EBV) that have come back or haven't responded to standard care. Doctors are using a bank of pre-made immune cells from healthy donors, which are specially trained to attack EBV-infected cancer cells, a…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for Tough-to-Treat throat cancer in Final-Stage trial
Disease control OngoingThis study is for people with advanced nasopharyngeal cancer (a type of throat cancer) that has returned or spread after they've already tried several other treatments, including immunotherapy and chemotherapy. It aims to see if a new drug called BL-B01D1 works better and is safe…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope drug enters first human tests for dozens of tough cancers
Disease control OngoingThis is an early-stage study to find a safe dose of a new drug called KFA115, given alone or with an existing immunotherapy (pembrolizumab), for people with advanced cancers that have stopped responding to standard treatments. The main goal is to check for side effects and determ…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Immunotherapy combo aims to boost survival in tough head & neck cancer
Disease control OngoingThis study is testing whether adding an immunotherapy drug (a PD-1 inhibitor) to standard chemotherapy before a patient's main cancer treatment can help people with advanced nasopharyngeal cancer live longer without their cancer returning. It involves 150 participants who are ran…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Mar 17, 2026 13:10 UTC
-
Triple-Threat attack on spreading head & neck cancer
Disease control OngoingThis study is testing a three-part treatment for nasopharyngeal cancer that has spread to a few other areas in the body. It combines a type of immunotherapy (PD-1 antibody), chemotherapy, and very precise, high-dose radiation (SBRT). The goal is to see if this combination can bet…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC